Looking to publish in Drugs in Context? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowDrugs in Context publishes peer-reviewed articles on pharmacotherapy and drug applications across therapeutic areas, focusing on original research papers and topical review articles while also considering systematic reviews and meta-analyses, editorials, case reports, conference reports, and Letters to the Editor.
Looking to publish in Drugs in Context? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Drugs in Context accepts the following article types. Click on an article type to view submission instructions.
Original Research Papers
Topical Review Articles
Systematic Reviews
Meta-Analyses
Reviews
Case Reports
Letters To The Editor
Case Series
Recent Publications
Deucravacitinib in dermatology: current indication and existing off-label data
Michela D’Agostino, Luca Potestio, Nello Tommasino, Matteo Megna
Primary Sjögren’s syndrome-associated interstitial lung disease: a case report with favourable response to tocilizumab
Negar Naseri, Nadia Jalili, Farzad Rafiei, Saina Sadeghipour, Hamidreza Soltani
GLP1 receptor agonists in heart failure with preserved ejection fraction (HFpEF) – beyond weight loss: a condensed scientific review
Elyzabeth Roy, Marie-Claude Parent, Anique Ducharme
Clinical profile, management and outcomes of patients taking dual pathway inhibition for cardiovascular protection in clinical practice in Latin America. Data from the XATOA registry
Juan Rene Cornejo-Avendaño, Carlos Novoa, Gerardo Peón, Carlos Rapallo, Alejandro Ricalde Alcocer, Nestor Alejandro Vita, Luis Ramón Virgen-Carrillo, Carlos Felipe Barrera-Ramírez, Eduardo Ramacciotti
Corrigendum: Evaluating the efficacy of curcumin plus serratiopeptidase formulation in inflammatory acne: a quasi-experimental study
Shakila Junaid, Kiran Naz Khan, Farina Zameer, Muhammad Mudassir, Sadaf Bukhari, Neeta Maheshwary, Muhammad Athar Khan
Frequently asked questions
How long does it take to publish?
Pre-submission enquiries normally receive a response within 48 hours. Manuscript suitability is normally assessed within 24 hours of submission.
Reformat to Drugs in Context using Livewrite PremiumIs a cover letter required?
A cover letter is required. It should address redundant publication, prior submission history if applicable, author approval and honesty statements, any additional information helpful to the editors, GPP3 compliance if appropriate, and any referring Editorial Board member if applicable.
Reformat to Drugs in Context using Livewrite PremiumWhat are the publication costs?
Standard APC: £2200 / US$3,050 / €2525 (+ VAT, where applicable). Fast Track + APC: £3600 / US$5000 / €4100 (+ VAT, where applicable). APC is payable only after acceptance. Case reports and Editorials qualify for a 50% APC discount. No submission fee applies.
Reformat to Drugs in Context using Livewrite Premium